A detailed history of Driehaus Capital Management LLC transactions in Codexis, Inc. stock. As of the latest transaction made, Driehaus Capital Management LLC holds 176,748 shares of CDXS stock, worth $747,644. This represents 0.01% of its overall portfolio holdings.

Number of Shares
176,748
Holding current value
$747,644
% of portfolio
0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$2.91 - $5.81 $514,336 - $1.03 Million
176,748 New
176,748 $843,000
Q2 2022

Aug 15, 2022

SELL
$8.35 - $21.89 $7.15 Million - $18.7 Million
-856,519 Reduced 63.17%
499,431 $5.22 Million
Q1 2022

May 16, 2022

SELL
$16.97 - $31.93 $819,871 - $1.54 Million
-48,313 Reduced 3.44%
1,355,950 $28 Million
Q4 2021

Feb 14, 2022

BUY
$25.61 - $41.78 $36 Million - $58.7 Million
1,404,263 New
1,404,263 $43.9 Million
Q3 2019

Nov 14, 2019

SELL
$12.75 - $19.01 $5.58 Million - $8.32 Million
-437,828 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$17.0 - $21.88 $3.82 Million - $4.92 Million
-224,828 Reduced 33.93%
437,828 $8.07 Million
Q1 2019

May 15, 2019

SELL
$15.53 - $22.15 $1.41 Million - $2.01 Million
-90,841 Reduced 12.06%
662,656 $13.6 Million
Q4 2018

Feb 14, 2019

BUY
$14.06 - $22.57 $360,118 - $578,085
25,613 Added 3.52%
753,497 $12.6 Million
Q3 2018

Nov 14, 2018

BUY
$13.35 - $19.1 $67,217 - $96,168
5,035 Added 0.7%
727,884 $12.5 Million
Q2 2018

Aug 14, 2018

BUY
$10.35 - $16.45 $3.26 Million - $5.18 Million
315,194 Added 77.32%
722,849 $10.4 Million
Q1 2018

May 15, 2018

BUY
$8.0 - $12.8 $3.26 Million - $5.22 Million
407,655 New
407,655 $4.48 Million

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $277M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.